Welcome to
On Feet Nation
jack Online
Khalid Shaikh Online
Michael Online
Posted by jack on September 14, 2024 at 5:14am 0 Comments 0 Likes
Posted by Khalid Shaikh on September 14, 2024 at 5:14am 0 Comments 0 Likes
Posted by Ruth on September 14, 2024 at 5:12am 0 Comments 0 Likes
The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for players engaged in the development of BBB penetrating drugs.
To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this https://www.rootsanalysis.com/reports/310/request-sample.html
The USD 940 million (by 2030) financial opportunity within the BBB market has been analyzed across the following segments:
Type of Payment Model Adopted
Upfront payments
Milestone payments
Type of Molecule
Small Molecules
Biologics
Target Disease Indication
Brain Metastases in Breast Cancer
Glioblastoma Multiforme
Hunter Syndrome
Hurler Syndrome
Leading Technology Platforms
G®-Technology
J-Brain Cargo® Technology
LRP-1 Technology
Trojan Horse Technology
Leading Drug Developers
2-BBB
Angiochem
ArmaGen
JCR Pharmaceuticals
Key Geographical Regions
North America
Europe
Asia-Pacific
The Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics report features the following companies, which we identified to be key players in this domain:
Angiochem
ArmaGen
BioArctic
Cyclenium Pharma
Denali Therapeutics
ICB International
Iproteos
JCR Pharmaceuticals
Lauren Sciences
Medesis Pharma
Ossianix
Vect-Horus
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Non-Invasive BBB Penetration
5. Market Landscape: BBB Penetrating Drugs
6. Company Profiles
7. Technology Competitiveness Analysis
8. Non-Invasive BBB Penetration Technologies: Popular Approaches
9. Partnerships and Collaborations
10. Analysis of Recent Licensing Agreements
11. Funding and Investment Analysis
12. Patent Analysis
13. Drug Development Strategy Analysis
14. Market Potential of Key Neurological Disorders
15. Likely Partner Analysis
16. Market Forecast
17. Conclusion
18. Executive Insights
19. Appendix 1: Tabulated Data
20. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/blood-brain-bar...
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation